top of page

Granulocyte Colony Stimulating Factor Biosimilars: An Update for Frontline Oncology Practitioners

Thu, Feb 25, 2021 1:00 PM EST

*1.25 CNEs*

Learning objectives:

  • Discuss the current data supporting short- and long-acting granulocyte colony stimulating factor (G-CSF) use in prevention of febrile neutropenia and during the COVID-19 era

  • Formulate practical approaches to incorporating G-CSF biosimilars into healthcare system formularies and/or clinical pathways

  • Recognize the need for educational interventions that will improve healthcare providers’ understanding of G-CSF biosimilars use in cancer supportive care

3 views0 comments

Recent Posts

See All

Cancer Equity Colloquium 2024

Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequitie


bottom of page